Clinical Trial Update: CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CIK-Cells in relapsing patients with acute leukemia or myelodysplastic syndromes after stem cell transplant (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CIK Cells

Snippet

Sponsor: Peter Bader | Conditions: Myelodysplastic Syndromes, Acute Leukemia | Phase 1, Phase 2 | Status: UNKNOWN